Teeli A, Luczynska K, Haque E, Gayas M, Winiarczyk D, Taniguchi H
Cancers (Basel). 2021; 13(21).
PMID: 34771521
PMC: 8582545.
DOI: 10.3390/cancers13215357.
Lv D, Zhou L, Tang H
Exp Mol Med. 2021; 53(1):8-18.
PMID: 33462379
PMC: 8080681.
DOI: 10.1038/s12276-020-00551-1.
Spaninger E, Potocnik U, Bren U
Biomolecules. 2020; 10(12).
PMID: 33371430
PMC: 7767403.
DOI: 10.3390/biom10121700.
Kim J, Jeong H, Heo D, Keam B, Moon K, Kwak C
Ann Transl Med. 2020; 8(21):1389.
PMID: 33313134
PMC: 7723617.
DOI: 10.21037/atm-20-3466.
Lu J, Chen Z, Zhao H, Dong H, Zhu L, Zhang Y
J Transl Med. 2020; 18(1):101.
PMID: 32093682
PMC: 7038561.
DOI: 10.1186/s12967-020-02268-1.
Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence.
Wang Z, Li Y, Wu D, Yu S, Wang Y, Chan F
Oncogene. 2019; 39(7):1572-1589.
PMID: 31695151
PMC: 7018660.
DOI: 10.1038/s41388-019-1080-3.
Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases.
Yeh M, Bosch D, Daoud S
World J Gastroenterol. 2019; 25(30):4074-4091.
PMID: 31435165
PMC: 6700705.
DOI: 10.3748/wjg.v25.i30.4074.
HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
Gao Y, Yan Y, Guo J, Zhang Q, Bi D, Wang F
Oncol Rep. 2019; 42(3):1066-1074.
PMID: 31322246
PMC: 6667891.
DOI: 10.3892/or.2019.7214.
Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.
Siebenthall K, Miller C, Vierstra J, Mathieu J, Tretiakova M, Reynolds A
EBioMedicine. 2019; 41:427-442.
PMID: 30827930
PMC: 6441874.
DOI: 10.1016/j.ebiom.2019.01.063.
Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma.
Cai S, Lu S, Liu L, Zhang C, Yun J
Therap Adv Gastroenterol. 2017; 10(10):761-771.
PMID: 29051787
PMC: 5638181.
DOI: 10.1177/1756283X17725998.
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.
Gao Y, Wu Z, Xie L, Li C, Mao Y, Duan Y
Nat Commun. 2017; 8:15337.
PMID: 28643803
PMC: 5481740.
DOI: 10.1038/ncomms15337.
Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.
Mehra R, Vats P, Cieslik M, Cao X, Su F, Shukla S
Cancer Discov. 2016; 6(11):1258-1266.
PMID: 27604489
PMC: 5096979.
DOI: 10.1158/2159-8290.CD-16-0267.
Extensive decoupling of metabolic genes in cancer.
Reznik E, Sander C
PLoS Comput Biol. 2015; 11(5):e1004176.
PMID: 25961905
PMC: 4427321.
DOI: 10.1371/journal.pcbi.1004176.
Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer.
Walesky C, Apte U
Gene Expr. 2015; 16(3):101-8.
PMID: 25700366
PMC: 5841246.
DOI: 10.3727/105221615X14181438356292.
Localization of hepatocyte nuclear factor-4α in the nucleolus and nucleus is regulated by its C-terminus.
Ogata M, Awaji T, Iwasaki N, Fujimaki R, Takizawa M, Maruyama K
J Diabetes Investig. 2014; 3(5):449-56.
PMID: 24843605
PMC: 4019245.
DOI: 10.1111/j.2040-1124.2012.00210.x.
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Strong M, Xu G, Coco J, Baribault C, Vinay D, Lacey M
PLoS Pathog. 2013; 9(5):e1003341.
PMID: 23671415
PMC: 3649992.
DOI: 10.1371/journal.ppat.1003341.
Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a review.
Azmi A, Bao G, Gao J, Mohammad R, Sarkar F
Curr Drug Discov Technol. 2012; 10(2):147-54.
PMID: 23237677
PMC: 3820112.
DOI: 10.2174/1570163811310020007.
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
Lockwood W, Wilson I, Coe B, Chari R, Pikor L, Thu K
PLoS One. 2012; 7(5):e37775.
PMID: 22629454
PMC: 3357406.
DOI: 10.1371/journal.pone.0037775.
A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.
Wirsing A, Senkel S, Klein-Hitpass L, Ryffel G
PLoS One. 2011; 6(11):e27438.
PMID: 22140441
PMC: 3227676.
DOI: 10.1371/journal.pone.0027438.
Inhibitor of the tissue-specific transcription factor HNF4, a potential regulator in early Xenopus development.
Peiler G, Bockmann B, Nakhei H, Ryffel G
Mol Cell Biol. 2000; 20(23):8676-83.
PMID: 11073969
PMC: 86478.
DOI: 10.1128/MCB.20.23.8676-8683.2000.